Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SECOM, Oct-Dec (3Q) Ordinary Profit Increases by 6%
9735 SECOM CO., LTD. 【J-GAAP】
Earnings ReportSECOM CO., LTD. <9735> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) was 127 billion yen, a 1.2% decrease compared to the same period last year. Progress toward the full-year plan of 168 billion yen was 75.7%, also surpassing the five-year average of 73.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 10.5% from the same period last year to 40.9 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 6.4% from the same period last year, reaching 48.7 billion yen. The operating profit margin rose from 13.5% in the same period last year to 13.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 835,626 | 103,644 | 119,721 | 76,346 | 180.1 | 71.7 | Feb 8, 2024 | J-GAAP |
| Apr - Dec, 2024 | 864,615 | 100,259 | 129,375 | 79,445 | 190.9 | 73.9 | Feb 12, 2025 | J-GAAP |
| Apr - Dec, 2025 | 909,805 | 110,714 | 127,768 | 78,465 | 191.8 | 75.7 | Feb 13, 2026 | J-GAAP |
| YoY | +5.2% | +10.4% | -1.2% | -1.2% | +0.5% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 639,746 | 85,198 | 91,529 | 57,688 | 138.7 | 50 | May 12, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 657,453 | 82,536 | 89,637 | 54,298 | 134.2 | 50 | Nov 11, 2025 | J-GAAP |
| YoY | +2.8% | -3.1% | -2.1% | -5.9% | -3.2% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 1,154,740 | 140,658 | 166,859 | 101,951 | 241.0 | 95 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 1,199,942 | 144,297 | 175,123 | 108,109 | 260.0 | 97.50 | May 12, 2025 | J-GAAP |
| Mar, 2026 Guidance | 1,251,000 | 150,000 | 168,700 | 103,400 | 255.6 | 100 | May 12, 2025 | J-GAAP |
| YoY | +4.3% | +4.0% | -3.7% | -4.4% | -1.7% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 304,419 | 41,160 | 45,781 | 29,024 | 69.8 | 13.5 | Feb 12, 2025 | J-GAAP |
| Jan - Mar, 2025 | 335,327 | 44,038 | 45,748 | 28,664 | 68.9 | 13.1 | May 12, 2025 | J-GAAP |
| Apr - Jun, 2025 | 287,992 | 32,219 | 39,333 | 24,939 | 60.2 | 11.2 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 305,555 | 35,245 | 39,730 | 24,163 | 58.8 | 11.5 | Nov 11, 2025 | J-GAAP |
| Oct - Dec, 2025 | 316,258 | 43,250 | 48,705 | 29,363 | 71.8 | 13.7 | Feb 13, 2026 | J-GAAP |
| YoY | +3.9% | +5.1% | +6.4% | +1.2% | +2.9% |
Related Articles
Focus Systems, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 55%, Current Fiscal Year Dividend Revised Upward by 8 Yen
D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Widen
KURODA PRECISION INDUSTRIES, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Turns to Loss
Branding Tech, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 63%, Oct-Dec Ordinary Profit Decreases by 26%
Nakanihon KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Exceeds Full-Year Plan
Fukui Computer, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 13%, Exceeded Record Profit Forecast
Ficha, First Half Ordinary Profit Loss Widens
MatsukiyoCocokara, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%
Solasia Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
ULS Group, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 16%, Oct-Dec Ordinary Profit Increases by 35%